hu.MAP 3.0: Complex View

Human Protein Complex Map

Complex: huMAP3_09622.1

Complex Portal: CPX-18434

Confidence: Moderate High

Genename	Protein Name	Uniprot Annotation Score	Links
CDKN2D	Cyclin-dependent kinase 4 inhibitor D (p19-INK4d)	5	UniProt NCBI
FGR	Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr)	5	UniProt NCBI
CDKN2B	Cyclin-dependent kinase 4 inhibitor B (Multiple tumor suppressor 2) (MTS-2) (p14-INK4b) (p15-INK4b) (p15INK4B)	5	UniProt NCBI
CDK4	Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3)	5	UniProt NCBI
CDK6	Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE)	5	UniProt NCBI
CDKN2A	Tumor suppressor ARF (Alternative reading frame) (ARF) (Cyclin-dependent kinase inhibitor 2A) (p14ARF)	5	UniProt NCBI
CDKN2C	Cyclin-dependent kinase 4 inhibitor C (Cyclin-dependent kinase 6 inhibitor) (p18-INK4c) (p18-INK6)	5	UniProt NCBI

Enrichments

Term ID	Corrected Pval	Fraction Complex Coverage	Proteins	Term Name
REAC:R-HSA-2559585	4.70658760476e-11	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Oncogene Induced Senescence
REAC:R-HSA-69231	2.71631032929e-10	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Cyclin D associated events in G1
REAC:R-HSA-69236	2.71631032929e-10	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	G1 Phase
WP:WP45	5.89007572933e-10	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	G1 to S cell cycle control
WP:WP179	1.23535088637e-08	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Cell cycle
REAC:R-HSA-2559582	1.27335011764e-08	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Senescence-Associated Secretory Phenotype (SASP)
REAC:R-HSA-2559580	2.09928242806e-08	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Oxidative Stress Induced Senescence
KEGG:04110	3.3935086085e-08	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Cell cycle
GO:0004861	4.97036464355e-08	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	cyclin-dependent protein serine/threonine kinase inhibitor activity
REAC:R-HSA-453279	1.05210790032e-07	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Mitotic G1 phase and G1/S transition
REAC:R-HSA-2559583	2.53969571779e-07	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Cellular Senescence
WP:WP2261	7.60204280189e-07	0.666666666667	CDKN2C CDK6 CDKN2B CDKN2A	Glioblastoma signaling pathways
WP:WP3998	1.03160505501e-06	0.666666666667	CDKN2C CDK6 CDKN2B CDKN2A	Prader Willi and Angelman syndrome
KEGG:04934	3.90742608633e-06	0.666666666667	CDKN2C CDK6 CDKN2B CDKN2A	Cushing syndrome
WP:WP2877	5.77362685457e-06	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	Vitamin D receptor pathway
GO:0030291	8.06004189332e-06	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	protein serine/threonine kinase inhibitor activity
HP:0006744	2.0067945866e-05	0.5	CDKN2A CDKN2B CDKN2C	Adrenocortical carcinoma
HP:0002888	2.40778245812e-05	0.5	CDKN2A CDKN2B CDKN2C	Ependymoma
GO:0016538	4.39939518846e-05	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	cyclin-dependent protein serine/threonine kinase regulator activity
HP:0100641	5.22168897407e-05	0.5	CDKN2A CDKN2B CDKN2C	Neoplasm of the adrenal cortex
GO:0000082	5.45422005277e-05	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	G1/S transition of mitotic cell cycle
HP:0003118	5.96672480776e-05	0.5	CDKN2A CDKN2B CDKN2C	Increased circulating cortisol level
REAC:R-HSA-69278	6.34457226533e-05	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Cell Cycle, Mitotic
REAC:R-HSA-9630747	7.74455426548e-05	0.333333333333	CDK6 CDKN2A	Diseases of Cellular Senescence
REAC:R-HSA-9675132	7.74455426548e-05	0.333333333333	CDK6 CDKN2A	Diseases of cellular response to stress
REAC:R-HSA-9632693	7.74455426548e-05	0.333333333333	CDK6 CDKN2A	Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects
REAC:R-HSA-9630750	7.74455426548e-05	0.333333333333	CDK6 CDKN2A	Evasion of Oncogene Induced Senescence Due to p16INK4A Defects
REAC:R-HSA-9632700	7.74455426548e-05	0.333333333333	CDK6 CDKN2A	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
REAC:R-HSA-9630794	7.74455426548e-05	0.333333333333	CDK6 CDKN2A	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
GO:0044843	0.000101856377733	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	cell cycle G1/S phase transition
GO:0000079	0.000155002771391	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	regulation of cyclin-dependent protein serine/threonine kinase activity
HP:0002717	0.000176135758605	0.5	CDKN2A CDKN2B CDKN2C	Adrenal overactivity
REAC:R-HSA-1640170	0.000178011057657	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Cell Cycle
GO:0004860	0.000178553196738	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	protein kinase inhibitor activity
GO:1904029	0.000204687081424	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	regulation of cyclin-dependent protein kinase activity
GO:0019210	0.000233586241151	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	kinase inhibitor activity
HP:0100631	0.000290543404042	0.5	CDKN2A CDKN2B CDKN2C	Neoplasm of the adrenal gland
REAC:R-HSA-2262752	0.000309290917502	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Cellular responses to stress
REAC:R-HSA-8953897	0.000324464342864	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	Cellular responses to stimuli
HP:0009733	0.000416966817366	0.5	CDKN2A CDKN2B CDKN2C	Glioma
GO:1901990	0.000527042398814	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	regulation of mitotic cell cycle phase transition
HP:0011731	0.000541046995004	0.5	CDKN2A CDKN2B CDKN2C	Abnormality of circulating cortisol level
HP:0002890	0.000541046995004	0.5	CDKN2A CDKN2B CDKN2C	Thyroid carcinoma
HP:0012111	0.000575493098093	0.5	CDKN2A CDKN2B CDKN2C	Abnormality of circulating glucocorticoid level
KEGG:04218	0.000872061762815	0.5	CDK6 CDKN2B CDKN2A	Cellular senescence
HP:0012197	0.00107987178333	0.333333333333	CDKN2B CDKN2C	Insulinoma
HP:0011759	0.00107987178333	0.333333333333	CDKN2B CDKN2C	Pituitary gonadotropic cell adenoma
HP:0040306	0.00107987178333	0.333333333333	CDKN2B CDKN2C	Decreased male libido
HP:0011761	0.00107987178333	0.333333333333	CDKN2B CDKN2C	Pituitary null cell adenoma
HP:0005605	0.00107987178333	0.333333333333	CDKN2B CDKN2C	Large cafe-au-lait macules with irregular margins
HP:0011762	0.00107987178333	0.333333333333	CDKN2B CDKN2C	Pituitary thyrotropic cell adenoma
HP:0100522	0.00107987178333	0.333333333333	CDKN2B CDKN2C	Thymoma
HP:0030404	0.00161951205762	0.333333333333	CDKN2B CDKN2C	Glucagonoma
HP:0500167	0.00161951205762	0.333333333333	CDKN2B CDKN2C	Hypergastrinemia
HP:0006780	0.00161951205762	0.333333333333	CDKN2B CDKN2C	Parathyroid carcinoma
HP:0006723	0.00161951205762	0.333333333333	CDKN2B CDKN2C	Intestinal carcinoid
HP:0500166	0.00161951205762	0.333333333333	CDKN2B CDKN2C	Abnormal circulating gastrin concentration
GO:0044772	0.00189135577713	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	mitotic cell cycle phase transition
GO:1901987	0.00197696924536	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	regulation of cell cycle phase transition
KEGG:05203	0.00204140619094	0.5	CDK6 CDKN2B CDKN2A	Viral carcinogenesis
GO:0045859	0.0021887988316	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A FGR	regulation of protein kinase activity
HP:0031094	0.0022669030801	0.333333333333	CDKN2B CDKN2C	Abnormal breast physiology
HP:0006767	0.0022669030801	0.333333333333	CDKN2B CDKN2C	Pituitary prolactin cell adenoma
HP:0100829	0.0022669030801	0.333333333333	CDKN2B CDKN2C	Galactorrhea
HP:0100521	0.0022669030801	0.333333333333	CDKN2B CDKN2C	Neoplasm of the thymus
HP:0040085	0.0022669030801	0.333333333333	CDKN2B CDKN2C	Abnormal circulating aldosterone
HP:0002894	0.0023115348624	0.5	CDKN2A CDKN2B CDKN2C	Neoplasm of the pancreas
GO:0006468	0.00232878531203	1.0	CDKN2A FGR CDKN2D CDKN2B CDK6 CDKN2C	protein phosphorylation
HP:0100031	0.00240122360395	0.5	CDKN2A CDKN2B CDKN2C	Neoplasm of the thyroid gland
KEGG:05166	0.00246039647578	0.5	CDKN2A CDKN2B CDKN2C	Human T-cell leukemia virus 1 infection
HP:0030063	0.00249319307056	0.5	CDKN2A CDKN2B CDKN2C	Neuroepithelial neoplasm
HP:0030061	0.00258747141385	0.5	CDKN2A CDKN2B CDKN2C	Neuroectodermal neoplasm
HP:0030060	0.00258747141385	0.5	CDKN2A CDKN2B CDKN2C	Nervous tissue neoplasm
HP:0001579	0.00302198579101	0.333333333333	CDKN2B CDKN2C	Primary hypercortisolism
HP:0008261	0.00302198579101	0.333333333333	CDKN2B CDKN2C	Pancreatic islet cell adenoma
HP:0100836	0.00320320212918	0.5	CDKN2A CDKN2B CDKN2C	Malignant neoplasm of the central nervous system
GO:0043549	0.00326776684317	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A FGR	regulation of kinase activity
HP:0011732	0.00354451215187	0.5	CDKN2A CDKN2B CDKN2C	Abnormal adrenal morphology
HP:0031071	0.00354451215187	0.5	CDKN2A CDKN2B CDKN2C	Abnormal endocrine morphology
GO:0008285	0.00367725480237	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	negative regulation of cell population proliferation
GO:0007346	0.00382249285592	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	regulation of mitotic cell cycle
HP:0000849	0.00388470114881	0.333333333333	CDKN2B CDKN2C	Adrenocortical abnormality
HP:0002044	0.00388470114881	0.333333333333	CDKN2B CDKN2C	Zollinger-Ellison syndrome
HP:0007449	0.00388470114881	0.333333333333	CDKN2B CDKN2C	Confetti-like hypopigmented macules
HP:0046504	0.00388470114881	0.333333333333	CDKN2B CDKN2C	Decreased libido
HP:0032044	0.00388470114881	0.333333333333	CDKN2B CDKN2C	Decreased vigilance
HP:0008208	0.00388470114881	0.333333333333	CDKN2B CDKN2C	Parathyroid hyperplasia
HP:0030445	0.00388470114881	0.333333333333	CDKN2B CDKN2C	Pulmonary carcinoid tumor
GO:0016310	0.00393304186908	1.0	CDKN2A FGR CDKN2D CDKN2B CDK6 CDKN2C	phosphorylation
GO:2000045	0.00402421791763	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	regulation of G1/S transition of mitotic cell cycle
WP:WP4204	0.00436073489596	0.333333333333	CDK6 CDKN2A	Tumor suppressor activity of SMARCB1
HP:0002039	0.00457065401807	0.5	CDKN2A CDKN2B CDKN2C	Anorexia
HP:0012232	0.00485499013014	0.333333333333	CDKN2B CDKN2C	Shortened QT interval
HP:0002588	0.00485499013014	0.333333333333	CDKN2B CDKN2C	Duodenal ulcer
HP:0008200	0.00485499013014	0.333333333333	CDKN2B CDKN2C	Primary hyperparathyroidism
HP:0011733	0.00515033446185	0.5	CDKN2A CDKN2B CDKN2C	Abnormality of adrenal physiology
GO:0044770	0.00567613747193	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	cell cycle phase transition
HP:0000845	0.00593279372985	0.333333333333	CDKN2B CDKN2C	Elevated circulating growth hormone concentration
HP:0030448	0.00662835320171	0.5	CDKN2A CDKN2B CDKN2C	Soft tissue sarcoma
HP:0003144	0.00711805296098	0.333333333333	CDKN2B CDKN2C	Increased serum serotonin
HP:0030405	0.00711805296098	0.333333333333	CDKN2B CDKN2C	Pancreatic endocrine tumor
HP:0008291	0.00711805296098	0.333333333333	CDKN2B CDKN2C	Pituitary corticotropic cell adenoma
GO:1902806	0.00745537756816	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	regulation of cell cycle G1/S phase transition
HP:0100570	0.00841070885474	0.333333333333	CDKN2B CDKN2C	Carcinoid tumor
HP:0011151	0.00841070885474	0.333333333333	CDKN2B CDKN2C	Atypical absence status epilepticus
HP:0032860	0.00981070246055	0.333333333333	CDKN2B CDKN2C	Generalized non-convulsive status epilepticus without coma
GO:0051338	0.0105932770836	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A FGR	regulation of transferase activity
HP:0100733	0.011317974846	0.333333333333	CDKN2B CDKN2C	Neoplasm of the parathyroid gland
HP:0011407	0.011317974846	0.333333333333	CDKN2B CDKN2C	Proportionate tall stature
HP:0011760	0.011317974846	0.333333333333	CDKN2B CDKN2C	Pituitary growth hormone cell adenoma
HP:0100568	0.0113637882169	0.5	CDKN2A CDKN2B CDKN2C	Neoplasm of the endocrine system
GO:0019901	0.0127449784198	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A FGR	protein kinase binding
HP:0002248	0.0129324670968	0.333333333333	CDKN2B CDKN2C	Hematemesis
HP:0032671	0.0129324670968	0.333333333333	CDKN2B CDKN2C	Non-convulsive status epilepticus without coma
HP:0100705	0.0129601794289	0.5	CDKN2A CDKN2B CDKN2C	Abnormal glial cell morphology
KEGG:05218	0.0135980974704	0.333333333333	CDK6 CDKN2A	Melanoma
HP:0012091	0.0141028469624	0.5	CDKN2A CDKN2B CDKN2C	Abnormality of pancreas physiology
GO:0019887	0.0142903488279	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	protein kinase regulator activity
KEGG:04115	0.0144916673313	0.333333333333	CDK6 CDKN2A	p53 signaling pathway
HP:0000169	0.0146541203169	0.333333333333	CDKN2B CDKN2C	Gingival fibromatosis
KEGG:05223	0.0163630378499	0.333333333333	CDK6 CDKN2A	Non-small cell lung cancer
KEGG:05214	0.0163630378499	0.333333333333	CDK6 CDKN2A	Glioma
HP:0011766	0.0164828756284	0.333333333333	CDKN2B CDKN2C	Abnormal parathyroid morphology
HP:0002249	0.0164828756284	0.333333333333	CDKN2B CDKN2C	Melena
HP:0032367	0.0164828756284	0.333333333333	CDKN2B CDKN2C	Abnormal growth hormone level
HP:0011772	0.0165841502586	0.5	CDKN2A CDKN2B CDKN2C	Abnormal thyroid morphology
WP:WP4685	0.0176466803728	0.333333333333	CDK6 CDKN2A	Melanoma
HP:0100242	0.0179262368461	0.5	CDKN2A CDKN2B CDKN2C	Sarcoma
KEGG:05212	0.0183465080486	0.333333333333	CDK6 CDKN2A	Pancreatic cancer
HP:0000847	0.0184186741717	0.333333333333	CDKN2B CDKN2C	Abnormality of renin-angiotensin system
HP:0031475	0.0184186741717	0.333333333333	CDKN2B CDKN2C	Status epilepticus without prominent motor symptoms
HP:0100006	0.01897859059	0.5	CDKN2A CDKN2B CDKN2C	Neoplasm of the central nervous system
KEGG:05220	0.0193802025824	0.333333333333	CDK6 CDKN2A	Chronic myeloid leukemia
HP:0034902	0.020461457105	0.333333333333	CDKN2B CDKN2C	Abnormal circulating calcitonin concentration
HP:0003528	0.020461457105	0.333333333333	CDKN2B CDKN2C	Elevated circulating calcitonin concentration
WP:WP4255	0.0220152039288	0.333333333333	CDK6 CDKN2A	Non small cell lung cancer
GO:0071900	0.0221134397151	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	regulation of protein serine/threonine kinase activity
GO:0010564	0.0221505086962	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	regulation of cell cycle process
HP:0000843	0.0226111656051	0.333333333333	CDKN2B CDKN2C	Hyperparathyroidism
HP:0000834	0.0231853700795	0.5	CDKN2A CDKN2B CDKN2C	Abnormality of the adrenal glands
KEGG:01522	0.0237939838034	0.333333333333	CDKN2A CDKN2C	Endocrine resistance
GO:0019900	0.0237947057319	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A FGR	kinase binding
WP:WP4674	0.0240332707265	0.333333333333	CDK6 CDKN2A	Head and neck squamous cell carcinoma
HP:0004375	0.024855550682	0.5	CDKN2A CDKN2B CDKN2C	Neoplasm of the nervous system
KEGG:05222	0.0261678409889	0.333333333333	CDK6 CDKN2B	Small cell lung cancer
GO:0019207	0.0265218418455	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	kinase regulator activity
KEGG:05200	0.0272817161758	0.5	CDK6 CDKN2B CDKN2A	Pathways in cancer
GO:0042326	0.0298049910182	0.666666666667	CDKN2C CDKN2D CDKN2B CDKN2A	negative regulation of phosphorylation
WP:WP4263	0.0321785953671	0.333333333333	CDK6 CDKN2A	Pancreatic adenocarcinoma pathway
HP:0020073	0.0322780794397	0.333333333333	CDKN2B CDKN2C	Hypopigmented macule
GO:1903047	0.0327119049052	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A CDK6	mitotic cell cycle process
HP:0002666	0.0349615340576	0.333333333333	CDKN2B CDKN2C	Pheochromocytoma
GO:0001932	0.0376132764513	0.833333333333	CDKN2C CDKN2D CDKN2B CDKN2A FGR	regulation of protein phosphorylation
HP:0006476	0.037751561683	0.333333333333	CDKN2B CDKN2C	Abnormality of the pancreatic islet cells
WP:WP4658	0.0388355255908	0.333333333333	CDK6 CDKN2B	Small cell lung cancer
HP:0012093	0.0406481036194	0.333333333333	CDKN2B CDKN2C	Abnormality of endocrine pancreas physiology
HP:0001012	0.0406481036194	0.333333333333	CDKN2B CDKN2C	Multiple lipomas
KEGG:04068	0.045081780015	0.333333333333	CDKN2D CDKN2B	FoxO signaling pathway
HP:0040202	0.0461031757991	0.5	CDKN2A CDKN2B CDKN2C	Abnormal consumption behavior
CORUM:3088	0.0499436884912	0.166666666667	CDK6	CCND2-CDK6 complex
CORUM:3089	0.0499436884912	0.166666666667	CDK6	CCND3-CDK6 complex
CORUM:1642	0.0499436884912	0.166666666667	CDKN2A	p16-cyclin D2-CDK4 complex
CORUM:5100	0.0499436884912	0.166666666667	CDK6	CyclinD3-CDK4-CDK6 complex
HP:0010615	0.0499762286031	0.333333333333	CDKN2B CDKN2C	Angiofibromas

Edges

Protein 1	Protein 2	Score	ProteomeHD	Interface Overlap	Evidence
CDK4	CDKN2C	1.0	0.138483660131	structurally_consistent (dimer)	bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116
CDK6	CDKN2C	1.0	0.120941176471	structurally_consistent (dimer)	bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116
CDK4	CDKN2A	0.998	0.182		hein_WMM bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM youn_WMM hein () gupta_WMM
CDKN2D	CDK6	0.997			bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116
CDKN2B	CDK4	0.996		structurally_consistent (dimer)	hein_WMM bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM hein () bioplex3_HCT116
CDKN2D	CDK4	0.995		structurally_consistent (P42772)	bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116
CDKN2B	CDK6	0.994			bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116
CDK4	CDK6	0.981	0.084		bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM bioplex3_HCT116
CDK6	CDKN2A	0.979	0.08		bioplex3_HEK293 bioplex () bioplex_WMM bioplex3_WMM
CDK4	FGR	0.979	0.2		bioplex3_WMM bioplex3_HCT116 WMM_only
CDKN2D	CDKN2B	0.96		structurally_consistent (dimer)	bioplex_WMM bioplex3_WMM WMM_only
CDKN2D	CDKN2C	0.95		structurally_consistent (P42772)	bioplex_WMM bioplex3_WMM WMM_only
CDKN2A	CDKN2C	0.924	0.084		bioplex_WMM bioplex3_WMM WMM_only
CDKN2B	CDKN2C	0.911		structurally_consistent (dimer)	bioplex_WMM bioplex3_WMM WMM_only
CDKN2B	CDKN2A	0.866			hein_WMM bioplex_WMM bioplex3_WMM WMM_only
CDKN2B	FGR	0.647			bioplex3_WMM WMM_only
CDKN2D	FGR	0.343			bioplex3_WMM WMM_only
CDKN2C	FGR	0.323	0.1		bioplex3_WMM WMM_only
CDKN2D	CDKN2A	0.295			bioplex_WMM bioplex3_WMM WMM_only
CDK6	FGR	0.206	0.13		bioplex3_WMM WMM_only
CDKN2A	FGR	0.024			bioplex3_WMM WMM_only

Related Complexes

Genename	Complexes
CDKN2D	huMAP3_01523.1 huMAP3_09622.1 huMAP3_10449.1 huMAP3_14722.1
FGR	huMAP3_03055.1 huMAP3_04688.1 huMAP3_06121.1 huMAP3_07971.1 huMAP3_09622.1 huMAP3_10449.1 huMAP3_13863.1 huMAP3_14722.1
CDKN2B	huMAP3_01523.1 huMAP3_09622.1 huMAP3_10449.1 huMAP3_14722.1
CDK4	huMAP3_01523.1 huMAP3_09622.1 huMAP3_10449.1 huMAP3_13837.1 huMAP3_14722.1
CDK6	huMAP3_01523.1 huMAP3_09622.1 huMAP3_10449.1 huMAP3_14722.1
CDKN2A	huMAP3_01523.1 huMAP3_02172.1 huMAP3_09622.1 huMAP3_10449.1 huMAP3_14722.1 huMAP3_14892.1
CDKN2C	huMAP3_01523.1 huMAP3_09622.1 huMAP3_10449.1 huMAP3_14722.1

hu.MAP 3.0: Complex View

Search for a protein

Complex: huMAP3_09622.1

Complex Portal: CPX-18434